Carregant...

Serotype-specific avidity is achieved following a single dose of the 7-valent pneumococcal conjugate vaccine, and is enhanced by 23-valent pneumococcal polysaccharide booster at 12 months

AIM: To evaluate whether the avidity of serotype-specific IgG to pneumococcal serotypes is enhanced by an increased number of doses of the 7-valent pneumococcal conjugate vaccine (PCV) in infancy or by a 12 month 23-valent pneumococcal polysaccharide vaccine (23vPPS) booster, and /or subsequent re-e...

Descripció completa

Guardat en:
Dades bibliogràfiques
Autors principals: Russell, FM, Balloch, A, Licciardi, PV, Carapetis, JR, Tikoduadua, L, Waqatakirewa, L, Cheung, YB, Mulholland, EK, Tang, MLK
Format: Artigo
Idioma:Inglês
Publicat: 2011
Matèries:
Accés en línia:https://ncbi.nlm.nih.gov/pmc/articles/PMC3114163/
https://ncbi.nlm.nih.gov/pubmed/21539882
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1016/j.vaccine.2011.04.038
Etiquetes: Afegir etiqueta
Sense etiquetes, Sigues el primer a etiquetar aquest registre!